An Israeli company is working on eye drops that could reverse a common type of vision loss: farsightedness or the inability to see or read nearby objects. Research on the Israel-based Orasis, Pharmaceuticals, eye drops indicates that the eye drops improve farsightedness and are tolerable.

“We are very encouraged by the results,” said Elad Kedar, CEO of Orasis, “The results were great not only on the efficacy endpoints, but also on the safety and tolerability, so we are moving as quickly as possible into Phase 3.”

Please contact SDCB if you would like to learn more about our vision rehabilitation services. We have many programs that can improve your life quality.

“Eye Drops To Reverse Vision Loss One Step Closer To Market”